Ventricular Septal Defect Treatment in Turkey

Understanding Ventricular Septal Defect and Its Symptoms

A Ventricular Septal Defect (VSD) is a structural birth anomaly characterized by an abnormal opening in the interventricular septum, the muscular wall separating the lower chambers of the heart. This opening allows oxygen-rich blood from the left ventricle to mix with oxygen-poor blood in the right ventricle, increasing the total volume of blood pumped towards the lungs. VSD is often identified during early childhood, but smaller or moderate defects can remain undetected until adolescence or adulthood.

The clinical presentation varies depending on the size and location of the hole within the septum. Infants with moderate to large defects typically display signs of heart failure within the first few weeks of life, including rapid breathing, excessive sweating during feeds, poor weight gain, and recurrent chest infections. In older children and adults, symptoms may manifest as persistent fatigue, decreased exercise tolerance, heart palpitations, or shortness of breath. Over time, an uncorrected large VSD can lead to pulmonary arterial hypertension, heart failure, and an increased risk of infective endocarditis.

How Ventricular Septal Defect is Diagnosed

Initial evaluation often begins when a physician detects a characteristic holosystolic heart murmur during a physical examination. To confirm the diagnosis and assess the defect's hemodynamic impact, specialist centers in Turkey perform comprehensive non-invasive and invasive diagnostic tests. Patients traveling for specialized evaluation are advised to compile their medical records beforehand, including previous clinical notes, medication lists, and prior diagnostic imaging.

Key diagnostic investigations usually involve:

• Transthoracic Echocardiogram (TTE): The primary diagnostic tool used to visualize the septum, measure the exact size and position of the defect, assess shunt volume, and evaluate pulmonary artery pressure.
• Transoesophageal Echocardiogram (TEE): Offers detailed imaging, particularly in adults or during procedure planning, by placing a probe down the oesophagus.
• Electrocardiogram (ECG) and Chest X-ray: Help identify signs of ventricular hypertrophy, atrial enlargement, or pulmonary vascular congestion.
• Cardiac MRI or CT: Provides precise three-dimensional visualization of complex structural anatomy when echocardiography is inconclusive.
• Diagnostic Cardiac Catheterisation: Used primarily when non-invasive imaging cannot definitively measure pulmonary vascular resistance or evaluate blood pressure within the heart chambers.

These procedures are frequently coordinated alongside initial evaluations within specialized departments like Cardiac Surgery or Paediatrics to establish an accurate surgical plan.

Treatment Options for Ventricular Septal Defect

Management strategies range from conservative clinical observation to active interventional closure. Small VSDs that do not cause heart strain or pulmonary hypertension often close spontaneously during early childhood or require no intervention other than routine monitoring. However, intervention is required when the defect causes symptomatic heart failure, significant left heart enlargement, or elevated pulmonary artery pressures. The appropriate approach is decided by the treating multidisciplinary team following direct review of diagnostic findings.

In complex congenital cases where additional structural repairs or diagnostics are necessary, multidisciplinary teams may involve specialists from Pulmonology & Thoracic Surgery or Check-ups & Diagnostics to manage overall heart and lung function.

Planning Ventricular Septal Defect Treatment in Turkey

International travel for cardiac care requires thorough advanced planning. Before traveling, patients or their guardians submit detailed medical records, echocardiograms, and relevant test results for preliminary remote review. Once accepted, the clinical team coordinates direct evaluations upon arrival to confirm suitability for catheter-based or open surgical intervention.

The length of stay varies significantly by the chosen procedure. Transcatheter closures typically require a stay of 3 to 5 days, including 1 to 2 days in the hospital for observation. Surgical patch repairs require a longer stay, usually 10 to 14 days in Turkey, which includes time in an intensive care unit, step-down ward care, and outpatient checks prior to flying home. Before discharge, the surgical team provides clear guidance regarding post-procedure medication, activity restrictions, wound care, and recommendations for long-term follow-up with a local cardiologist in the patient's home country.

Travel Restrictions and Urgent Medical Considerations

Patients with severe symptomatic VSD, severe pulmonary arterial hypertension (Eisenmenger syndrome), or severe uncontrolled heart failure must avoid air travel until thoroughly evaluated and stabilized by a cardiologist. Rapid atmospheric pressure changes can exacerbate hypoxia and right-to-left shunting in advanced cases.

Immediate local medical care is required if a patient experiences any of the following warning signs before or after treatment:

• Sudden or worsening shortness of breath at rest.
• Chest pain, pressure, or unexplained lightheadedness and fainting (syncope).
• Signs of surgical site infection, such as fever, redness, warmth, or drainage around the incision.
• Bluish discoloration of the lips, skin, or fingernails (cyanosis).
• Rapid, unexplained weight gain or swelling (oedema) in the legs, ankles, or abdomen.